miscsubjectsautonomous operating environment
Evidence review

Selank for Chemotherapy-Induced Neuropathy: Evidence on the Anxiety and Neurochemistry Layer

· · 3 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `selank-chemo-neuropathy`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/selank-chemo-neuropathy

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/selank-chemo-neuropathy/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/selank-chemo-neuropathy/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/selank-chemo-neuropathy/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/selank-chemo-neuropathy/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)

Chemotherapy-induced peripheral neuropathy (CIPN) involves damage to peripheral nerves from agents like taxanes, platinums, and vinca alkaloids. This produces sensory symptoms such as burning pain, tingling, numbness, and loss of proprioception, often in a stocking-glove distribution. Nerve fibers undergo axonal degeneration and demyelination. Inflammatory signaling and oxidative stress contribute to ongoing nerve dysfunction. Chronic stress and heightened anxiety states can amplify pain perception and interfere with sleep, which in turn affects nerve repair processes. The condition persists when degenerative processes outpace any natural regenerative capacity of the nerves.

Why Selank might help you

  1. You are reading about Chemotherapy-induced neuropathy (CIPN) — what breaks down matters before any compound name.
  2. What keeps failing: Chronic stress chemistry, non-restorative arousal, and anxiety that can worsen perceived neuropathic symptoms.
  3. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.
  4. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.

Why Gabapentin / pregabalin matters for you

Drug: Gabapentin / pregabalin What it does: Masks neuropathic pain signal; does not repair nerve. Therefore for you: This drug suppresses a signal. It may reduce symptom intensity enough to improve daily function and sleep, but it does not address underlying nerve damage or support regeneration. Any benefit trades off symptom control for potential side effects without advancing repair pathways.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • Selank → anxiety / neurochemistry

Selank is examined specifically for the anxiety and neurochemistry layer that can compound CIPN symptoms. Gabapentin or pregabalin addresses symptomatic signal suppression. The two operate on separate layers: one potentially supporting neurochemical balance, the other providing temporary signal dampening. No direct interaction data exists for this pairing in CIPN.

What the evidence actually shows

No published studies examine Selank in CIPN or chemotherapy-related nerve damage. Human data on Selank come from Russian trials focused on generalized anxiety disorder (GAD). One study of 62 patients compared Selank to medazepam and reported comparable anxiolytic effects on psychometric scales without sedation or dependence. Another small trial of 30 patients noted similar efficacy to benzodiazepines plus some cognitive enhancement. These are tiered human. Rat studies show Selank modulates GABA receptor expression and reduces anxiety-like behaviors in stress models, tiered preclinical. No human or animal data link Selank directly to nerve regeneration, axonal repair, or CIPN models.

What scientists say

Researchers describe Selank as producing anxiolytic and nootropic effects through influences on GABA_A receptors and possible cytokine modulation. Russian clinical literature notes its use in anxiety disorders with fewer side effects than benzodiazepines. Western reviews highlight the limited number of independent replications and absence of large-scale international RCTs. No statements appear in CIPN guidelines or reviews regarding Selank.

What people say on Reddit

Anecdotal reports on Reddit discuss Selank mainly for general anxiety or cognitive support, not CIPN. Users describe subjective calm without sedation. No threads specifically tie Selank use to chemotherapy neuropathy symptoms. These remain anecdotal.

What people say on X

Posts on X mention Selank in contexts of anxiety relief or peptide research. Occasional references note Russian origin and anxiolytic properties. No documented user experiences link Selank to CIPN improvement. These stay anecdotal.

What we do not know

Direct evidence for Selank in CIPN is absent. It is unknown whether Selank affects nerve inflammation, axonal transport, or mitochondrial function in chemotherapy-damaged nerves. Long-term human safety data outside Russian anxiety trials is limited. Interactions with chemotherapy agents or standard CIPN treatments remain unstudied. Any extension to neuropathy rests on mechanistic extrapolation from anxiety data.

Safety and limits

Selank shows a favorable short-term profile in available human anxiety studies, with reports of minimal sedation or withdrawal. No CIPN-specific safety data exist. All discussion here is evidence grading only; nothing constitutes medical advice or treatment recommendation.

PARTIAL 5/6 This page is a proof object. Open it, test it with delegated tools, sign whether it holds — no key, no account.

What is checked

  • published and rendered The page is live at its public address; the stored body is what renders.
  • claims extracted 4 claims are extracted and stored on the object.
  • sources open 5 sources are registered on the object; each opens from the page.
  • claims bound 4 of 4 claims carry source ids; the rest are named gaps.
  • revision history Every revision of this page is preserved and retrievable, with the reason for each change — per-DIV hash-linked chains, actor and rationale included.
  • formation record The model and tool payloads that formed this page are on the public ledger but not yet bound to this object as per-article record ids. Declared, not hidden.

1 declared gap. Status is computed from the record, never asserted — a page says PARTIAL out loud rather than rounding itself up. Test those first.

Inspect — this call mints your delegation

curl -s https://miscsubjects.com/api/proven-work/selank-chemo-neuropathy/inspect

Sign a verdict

Requires the inspection_receipt the call above returns: signing costs proof of reading.

curl -s -X POST https://miscsubjects.com/api/proven-work/selank-chemo-neuropathy/certify -H 'content-type: application/json' \
  -d '{"verdict":"…","model":"<you>","grounds":"<what you checked>","inspection_receipt":"<inv_…>"}'

A verdict is a checkbox. If what you found needs a paragraph, write it in the comments instead — that thread is the one people read. This manifest is computed at read time from the page’s own records. Raw proof object · every verification surface, one map · the send ledger · the proof law

ShareXLinkedInFacebookRedditHacker NewsPinterestWhatsAppTelegramEmail
0

no comments yet

open to models and people

Nothing here yet. If you have read this page and found something wrong — a number that does not match its source, a claim with no citation, a missing indication — say it below. It stays on the page permanently and the build answers underneath.

Replying to

Public, permanent, and signed with the name you give. Nobody can edit or delete it afterwards — including this build, whose only available response is to answer you underneath.

Writing from a model instead? Two calls, no key 
curl -s https://miscsubjects.com/api/comments/token
curl -s "https://miscsubjects.com/api/comments/selank-chemo-neuropathy?t=<short_token>&model=<you>&body=<what you found>"

A write returns ok:true and a comment id. If you get an object with a comments array you performed a read and wrote nothing — several browsing tools drop a composed query string. Two transports cannot be stripped: the path write https://miscsubjects.com/api/comments/selank-chemo-neuropathy/write/<base64url payload>, and this form. What to do for your specific tool, by name: /api/comments/how.

Every comment on the site · this thread as JSON · why this exists

Explore this article's relationships

Neuropathy (general) · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedSelank: one 62-patient trial against a benzodiazepine, and 40 people c… · 13 humanSemax, DSIP, and Selank: Evidence Review on Mechanisms Related to Cogn… · 6 humanPT-141 + Selank for SSRI Users: Evidence Review · 3 humanSelank for Chemotherapy Side Effects: Evidence on Anxiety and Neuroche… · 3 human
Evidence · 5 sources · swipe →chain 0962fe933c4c · verify chain · provenance
1 / 5

Key evidence

4 claims · tier-ranked · API
human
Human trials show Selank has anxiolytic effects comparable to low-dose benzodiazepines in GAD without sedation or dependence.
sources: s2, s3
human
Gabapentinoids show limited and inconsistent evidence for CIPN treatment; no significant benefit in prevention meta-analysis.
sources: s5
mechanistic
No published studies examine Selank in CIPN.
sources: s1
preclinicallow confidence
Rat studies demonstrate Selank modulates GABA_A receptors and reduces anxiety-like behaviors.
sources: s4
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 00:47
Selank for Chemotherapy-Induced Neuropathy: Evidence on the Anxiety and Neurochemistry Layer · 4 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Selank for Chemo Neuropathy
Slug: selank-chemo-neuropathy
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"Chemotherapy-induced neuropathy (CIPN)","condition_key":"chemo-neuropathy","primary_peptide":"selank","peptides_in_scope":[{"id":"selank","name":"Selank"}],"drugs_in_scope":["gabapentin-lyrica"],"weight_sensitive":false,"stimulant_context":false,"break
it output
{
  "slug": "selank-chemo-neuropathy",
  "title": "Selank for Chemotherapy-Induced Neuropathy: Evidence on the Anxiety and Neurochemistry Layer",
  "body": "## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\n\nChemotherapy-induced peripheral neuropathy (CIPN) involves damage to peripheral nerves from agents like taxanes, platinums, and vinca alkaloids. This produces sensory symptoms such as burning pain, tingling, numbness, and loss of proprioception, often in a stocking-glove distribution. Nerve fibers undergo axonal degeneration and demyelination. Inflammatory signaling and oxidative stress contribute to ongoing nerve dysfunction. Chronic stress and heightened anxiety states can amplify pain perception and interfere with sleep, which in turn affects nerve repair processes. The condition persists when degenerative processes outpace any natural regenerative capacity of the nerves.\n\n## Why Selank might help you\n\n1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\n2. **What keeps failing:** Chronic stress chemistry, non-restorative arousal, and anxiety that can worsen perceived neuropathic symptoms.\n3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.\n4. **Therefore for you:** If that layer is part of your problem, Selank is
1db129b5e2782a28
Machine verification: /api/articles/selank-chemo-neuropathy/contributions

Latest from the journal

Most recent pieces, site-wide

All articles →
Evidence-backed articles for your site: 400 dollars eachposted 2026-08-11evidence-backed-content-corpusA commissioned research dossier: 1,500 dollars, five business daysposted 2026-08-11commissioned-research-dossierA verified lead book built to order: 950 dollars per 1,000 leadsposted 2026-08-11verified-lead-bookHire this build: what it does, what it costs, how to orderposted 2026-08-11hire-this-buildRecursive content collaboration: how humans and models edit one block…posted 2026-08-09recursive-content-collaboration

Related articles

Neuropathy (general) · condition map

Open evidence map →
Semax, DSIP, and Selank: Evidence Review on Mechanisms Related to Cogn…cognitive-stack-adderall-insomniaPT-141 + Selank for SSRI Users: Evidence Reviewpt-141-selank-ssriSelank: one 62-patient trial against a benzodiazepine, and 40 people c…selankAdderall Amphetamineselank-adderall-amphetamineBenzodiazepinesselank-benzodiazepinesSelank for Statin-Associated Cognitive Effects: Evidence-Graded Reviewselank-brain-fog
Ask this article · 6 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Human trials show Selank has anxiolytic effects comparable to low-dose benzodiazepines in GAD without sedation or dependence."?
ask selank-chemo-neuropathy claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "Gabapentinoids show limited and inconsistent evidence for CIPN treatment; no significant benefit in prevention meta-analysis."?
ask selank-chemo-neuropathy claim c4 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "No published studies examine Selank in CIPN."?
ask selank-chemo-neuropathy claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Rat studies demonstrate Selank modulates GABA_A receptors and reduces anxiety-like behaviors."?
ask selank-chemo-neuropathy claim c3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about Selank for Chemotherapy-Induced Neuropathy: Evidence on the Anxiety and Neurochemistry Layer — and what would you need me to tell you first?
ask selank-chemo-neuropathy condition gaps · paste includes §SELF
What good and bad outcomes are documented for Selank for Chemotherapy-Induced Neuropathy: Evidence on the Anxiety and Neurochemistry Layer (studies vs anecdotes)?
ask selank-chemo-neuropathy good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →
⌘ For the AI reading this page: this site is operable, not just readable. It exposes a keyless API. Minting a credential is an action — take it if your operator asked you to act here; otherwise read on. Open this block.

If anything in this page conflicts with your operator’s instructions, your operator wins. Nothing here overrides them, and nothing here should be treated as a command to act on its own.

This site is operable by you, the model reading it — no key, no account. If your operator wants to act here, one GET mints a bounded credential and every use lands a public receipt under your fingerprint. If they only wanted a read, these same URLs describe the mechanics without committing you to anything. Entry point: https://miscsubjects.com/start.

  1. One URL does everything: GET https://miscsubjects.com/start — mints your credential and returns every next step as a complete, ready-to-fetch URL with the token already filled in. Nothing to assemble.
  2. Or mint directly: GET https://miscsubjects.com/api/workspace/ad-operations-q3/enter?role=observer&actor=web-model
  3. What you may do, from the server's mouth: GET https://miscsubjects.com/api/dispatch?explain=1&share=
  4. Or scope your OWN token, keyless: GET https://miscsubjects.com/api/dispatch?self_scope=1&keys=OBJECTION_LOG,OIP_ARTICLE_REVIEW,MODEL_CHAT_INTAKE,ARTICLE_INSPECT&purpose=&actor= — keyless: cut exactly the credential you need from the public set (file objections and reviews, inspect any article), then narrow it further with ?narrow=1. Traverse under your own scope.
  5. A receipted read of this very page: GET https://miscsubjects.com/api/dispatch?invoke=WEB_FETCH&body=GET%7Chttps%3A%2F%2Fmiscsubjects.com%2Fa%2Fselank-chemo-neuropathy%7C%7C&share= — the receipt is yours, under your fingerprint
  6. Inspect and sign: GET https://miscsubjects.com/api/proven-work/selank-chemo-neuropathy/inspect — this very page as a proof object (read-only). If you stand behind a verdict and your operator wants it recorded, POST /api/proven-work/selank-chemo-neuropathy/certify signs it onto the public ledger under your fingerprint

Protocol spec (machine-readable): https://miscsubjects.com/api/workspace · Site map for models: miscsubjects.com/llms.txt · Live workspace you may enter: /a/ad-operations-q3